Your browser doesn't support javascript.
loading
Systemic lupus erythematosus with autoimmune neurological manifestations in a carrier of chronic granulomatous disease - a rare presentation.
Prabhat, Nandita; Chakravarty, Kamalesh; Pattnaik, Shiv Narayan; Takkar, Aastha; Ray, Sucharita; Lal, Vivek.
Afiliação
  • Prabhat N; Department of Neurology, Postgraduate Institute of Medical Education and Research, (PGIMER), Chandigarh 160012, India.
  • Chakravarty K; Department of Neurology, Postgraduate Institute of Medical Education and Research, (PGIMER), Chandigarh 160012, India. Electronic address: drkamalesh70@gmail.com.
  • Pattnaik SN; Department of Neurology, Postgraduate Institute of Medical Education and Research, (PGIMER), Chandigarh 160012, India.
  • Takkar A; Department of Neurology, Postgraduate Institute of Medical Education and Research, (PGIMER), Chandigarh 160012, India.
  • Ray S; Department of Neurology, Postgraduate Institute of Medical Education and Research, (PGIMER), Chandigarh 160012, India.
  • Lal V; Department of Neurology, Postgraduate Institute of Medical Education and Research, (PGIMER), Chandigarh 160012, India.
J Neuroimmunol ; 343: 577229, 2020 06 15.
Article em En | MEDLINE | ID: mdl-32247876
ABSTRACT
Chronic granulomatous disease (CGD) is an uncommon genetic immunodeficiency disorder affecting neutrophil function, characterized by recurrent bacterial and fungal infections. X-linked carriers of CGD have an increased risk of autoimmune disorders, in particular lupus like disorders. We describe the case of a 37 years old female carrier of X-linked CGD, who presented with clinical features and serology consistent with a definite diagnosis of Systemic lupus erythematosus (SLE), with rare immune mediated neurological manifestations including secondary central nervous system (CNS) vasculitis and Longitudinally extensive transverse myelitis (LETM), responsive to immunomodulation. These neurological manifestations have not been described previously in carriers of CGD. We recommend early diagnosis of these immune mechanisms, especially in X-linked carriers of CGD, and appropriate immunomodulation in order to improve life expectancy and improve neurological outcome.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Granulomatosa Crônica / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Granulomatosa Crônica / Lúpus Eritematoso Sistêmico Idioma: En Ano de publicação: 2020 Tipo de documento: Article